MoneyWorks4Me

Aurobindo Pharma informs about press release

15 Sep 2026 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of USFDA Final approval for Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1858.95
Dr. Reddys Labs. 1169.00
Cipla 1375.90
Lupin 2083.85
Zydus Lifesciences 1135.55
View more..